Glutamate: A Safe Nutrient, Not Just a Simple Additive.


Journal

Annals of nutrition & metabolism
ISSN: 1421-9697
Titre abrégé: Ann Nutr Metab
Pays: Switzerland
ID NLM: 8105511

Informations de publication

Date de publication:
2022
Historique:
received: 26 11 2021
accepted: 04 02 2022
pubmed: 17 2 2022
medline: 14 6 2022
entrez: 16 2 2022
Statut: ppublish

Résumé

In 2017, a European Food Safety Authority (EFSA) opinion on the use of glutamate and its salts as food additives led to an Acceptable Daily Intake (ADI) of 30 mg/kg body weight/day. Then, in 2021, an EFSA statement presented a proposal for harmonizing the establishment of Health-Based Guidance Values for nutrients that are also regulated substances (including food additives). The present review argues that the 2017 glutamate ADI is unsuitable because safety of glutamate should firstly consider its status as a nutrient and not only as an additive. Glutamate is a non-essential amino acid playing a key role in nitrogen homeostasis. The dietary exposure to glutamate in adults is extensive, due to its ubiquitous presence in foods, under three forms: bound to proteins, naturally free and free form added as an additive. Glutamate naturally included in proteins is the major source of dietary glutamate. Thus, since it plays a role in nitrogen homeostasis, it is a nutrient before being an additive. Its pharmacokinetics are largely impacted by concomitant food intake, but the extent to which plasma glutamate concentration must rise to have deleterious effects is never encountered in humans consuming glutamate in their daily diets. This is due to the fact that glutamate is highly metabolized in the splanchnic area. Glutamate should be considered as a safe nutrient before being considered as an additive by risk assessor.

Sections du résumé

BACKGROUND
In 2017, a European Food Safety Authority (EFSA) opinion on the use of glutamate and its salts as food additives led to an Acceptable Daily Intake (ADI) of 30 mg/kg body weight/day. Then, in 2021, an EFSA statement presented a proposal for harmonizing the establishment of Health-Based Guidance Values for nutrients that are also regulated substances (including food additives). The present review argues that the 2017 glutamate ADI is unsuitable because safety of glutamate should firstly consider its status as a nutrient and not only as an additive.
SUMMARY
Glutamate is a non-essential amino acid playing a key role in nitrogen homeostasis. The dietary exposure to glutamate in adults is extensive, due to its ubiquitous presence in foods, under three forms: bound to proteins, naturally free and free form added as an additive. Glutamate naturally included in proteins is the major source of dietary glutamate. Thus, since it plays a role in nitrogen homeostasis, it is a nutrient before being an additive. Its pharmacokinetics are largely impacted by concomitant food intake, but the extent to which plasma glutamate concentration must rise to have deleterious effects is never encountered in humans consuming glutamate in their daily diets. This is due to the fact that glutamate is highly metabolized in the splanchnic area.
KEY MESSAGE
Glutamate should be considered as a safe nutrient before being considered as an additive by risk assessor.

Identifiants

pubmed: 35172302
pii: 000522482
doi: 10.1159/000522482
pmc: PMC9227671
doi:

Substances chimiques

Food Additives 0
Glutamic Acid 3KX376GY7L
Nitrogen N762921K75

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

133-146

Informations de copyright

© 2022 The Author(s). Published by S. Karger AG, Basel.

Références

Ann Nutr Metab. 2018;73 Suppl 5:53-64
pubmed: 30508819
EFSA J. 2021 Mar 18;19(3):e06479
pubmed: 33747231
Am J Clin Nutr. 1983 Jun;37(6):961-8
pubmed: 6133445
Am J Clin Nutr. 2006 Jan;83(1):115-23
pubmed: 16400059
Science. 1969 May 9;164(3880):719-21
pubmed: 5778021
J Nutr Biochem. 1999 Jun;10(6):331-7
pubmed: 15539307
Amino Acids. 2014 Sep;46(9):2075-87
pubmed: 24927698
J Nerv Ment Dis. 1955 Jan;121(1):40-9
pubmed: 14368312
Clin Nutr. 2008 Jun;27(3):321-7
pubmed: 18501998
Am J Clin Nutr. 1985 Aug;42(2):220-5
pubmed: 2862786
Am J Clin Nutr. 1984 May;39(5):722-9
pubmed: 6538743
Public Health Nutr. 2013 May;16(5):922-7
pubmed: 22894833
J Appl Physiol. 1954 Sep;7(2):196-9
pubmed: 13211498
Br J Nutr. 2010 Aug;104(3):457-63
pubmed: 20370941
Ann Nutr Metab. 2018;73 Suppl 5:5-14
pubmed: 30508813
Am J Clin Nutr. 1983 Feb;37(2):194-200
pubmed: 6823882
J Allergy Clin Immunol. 2000 Nov;106(5):973-80
pubmed: 11080723
Ann Nutr Metab. 2018;73 Suppl 5:15-20
pubmed: 30508814
Ann Nutr Metab. 2018;73 Suppl 5:21-28
pubmed: 30508815
J Psychiatr Res. 1989;23(3-4):241-9
pubmed: 2635221
Crit Rev Food Sci Nutr. 1983;18(3):231-312
pubmed: 6137322
Am J Physiol. 1993 Jun;264(6 Pt 1):E848-54
pubmed: 8101428
J Clin Endocrinol Metab. 1996 Jan;81(1):184-91
pubmed: 8550750
J Nutr. 2000 Apr;130(4S Suppl):983S-7S
pubmed: 10736366
J Nutr. 1982 Oct;112(10):1953-60
pubmed: 7119898
Ann Nutr Metab. 2018;73 Suppl 5:36-42
pubmed: 30508817
Am J Physiol. 1994 Jan;266(1 Pt 1):E151-4
pubmed: 7905708
Int J Epidemiol. 2018 Feb 1;47(1):311-320
pubmed: 29140419
Am J Physiol. 1997 Feb;272(2 Pt 1):G257-64
pubmed: 9124349
Metabolism. 1999 Nov;48(11):1455-60
pubmed: 10582557
J Hum Hypertens. 2003 Sep;17(9):591-608
pubmed: 13679950
Ann Nutr Metab. 2018;73 Suppl 5:1-4
pubmed: 30508812
Hepatology. 1991 Feb;13(2):247-53
pubmed: 1671664
Toxicol Appl Pharmacol. 1979 Sep 15;50(2):267-82
pubmed: 505457
Dis Mon. 2009 May;55(5):292-311
pubmed: 19362177
Eur J Clin Nutr. 2007 Mar;61(3):304-13
pubmed: 16957679
Ann Nutr Metab. 2018;73 Suppl 5:43-52
pubmed: 30508818
J Nutr. 1983 Sep;113(9):1851-60
pubmed: 6886827
Science. 1970 Sep 18;169(3951):1208-9
pubmed: 5450696
J Food Sci. 2017 Jan;82(1):16-23
pubmed: 27926796
J Clin Invest. 1971 Apr;50(4):814-7
pubmed: 5547277
Am J Clin Nutr. 1986 Apr;43(4):510-5
pubmed: 2870635
Am J Physiol Endocrinol Metab. 2000 Jan;278(1):E83-9
pubmed: 10644540
J Cell Physiol. 1988 Jan;134(1):143-8
pubmed: 2891715
Obesity (Silver Spring). 2008 Aug;16(8):1875-80
pubmed: 18497735
Am J Physiol. 1986 Jul;251(1 Pt 1):E117-26
pubmed: 2873746
J Nutr. 2015 Apr;145(4):720-8
pubmed: 25833775
Am J Clin Nutr. 2011 Jun;93(6):1328-36
pubmed: 21471280
EFSA J. 2017 Jul 12;15(7):e04910
pubmed: 32625571
Int J Neurosci. 1984 Apr;23(2):117-26
pubmed: 6541212
J Nutr. 2005 Sep;135(9):2166-70
pubmed: 16140893
World Health Organ Tech Rep Ser. 1987;759:1-53
pubmed: 3122426
Am J Physiol. 1995 Aug;269(2 Pt 1):E269-76
pubmed: 7653544
J Neurochem. 1987 May;48(5):1359-65
pubmed: 3559553
Am J Clin Nutr. 2013 Feb;97(2):403-10
pubmed: 23283504
J Nutr. 2000 Apr;130(4S Suppl):988S-90S
pubmed: 10736367
Circulation. 2009 Jul 21;120(3):221-8
pubmed: 19581495
Food Addit Contam. 1991 Sep-Oct;8(5):663-72
pubmed: 1818840
Nutr Metab (Lond). 2012 Jun 08;9(1):50
pubmed: 22681873
J Nutr. 2000 Apr;130(4S Suppl):892S-900S
pubmed: 10736349

Auteurs

Cécile Loï (C)

CITRAGE, Boissy St Léger, France.

Luc Cynober (L)

Laboratoire de Biologie de la Nutrition, URP 4466, Faculté de Pharmacie, Université de Paris, Paris, France.
Service de Biochimie, Hôpital Cochin, AP-HP, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH